Gene expression changes in steroid-induced IOP elevation in bovine trabecular meshwork

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 12, 2011, Pages 8636-8645

  Danias, John ^a,b   Gerometta, Rosana ^c   Ge, Yongchao ^c   Ren, Lizhen ^b   Panagis, Lampros ^b   Mittag, Thomas W ^c   Candia, Oscar A ^c   Podos, Steven M ^c  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b SUNY Downstate Medical Center   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALPHA INTEGRIN; ALPHA SMOOTH MUSCLE ACTIN; ANGIOTENSINOGEN; BETA 2 ADRENERGIC RECEPTOR; CALPONIN; CARBONATE DEHYDRATASE II; CELL ADHESION MOLECULE; CREATINE KINASE; DECAY ACCELERATING FACTOR; DESMIN; G PROTEIN COUPLED RECEPTOR; GLUCOCORTICOID; GLYCOSYLTRANSFERASE; HEAT SHOCK PROTEIN; IMMUNOGLOBULIN HEAVY CHAIN; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL ALPHA SUBUNIT; MYOSIN V; PHENYLALANINE 4 MONOOXYGENASE; PHOSPHOLAMBAN; PREDNISOLONE ACETATE; RAS PROTEIN; SMOOTHELIN; TRANSFORMING GROWTH FACTOR BETA1; TRANSGELIN; TRANSIENT RECEPTOR POTENTIAL CHANNEL A1; TROPOMYOSIN; TYROSINASE RELATED PROTEIN 1; ULTRA CORTENOL; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN; ANTIINFLAMMATORY AGENT; DRUG DERIVATIVE; PREDNISOLONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; COW; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; IMMUNOBLOTTING; INTRAOCULAR PRESSURE; MICROARRAY ANALYSIS; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRABECULAR MESHWORK; UPREGULATION; ANIMAL; BIOLOGICAL MODEL; BIOLOGY; CATTLE; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DNA MICROARRAY; DRUG EFFECT; GENE EXPRESSION; GENETICS; INTRAOCULAR HYPERTENSION; OPEN ANGLE GLAUCOMA; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CATTLE; COMPUTATIONAL BIOLOGY; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; GLAUCOMA, OPEN-ANGLE; INTRAOCULAR PRESSURE; MODELS, GENETIC; OCULAR HYPERTENSION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREDNISOLONE; REAL-TIME POLYMERASE CHAIN REACTION; TRABECULAR MESHWORK;

EID: 84855414473     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-7563     Document Type: Article

References (72)

1. Bernstein HN, Mills DW, Becker B. Steroid-induced elevation of intraocular pressure. Arch Ophthalmol. 1963;70:15-18.
2. Becker B, Mills DW. Elevated intraocular pressure following corticosteroid eye drops. J Am Med Assoc. 1963;185:884-886.
3. Becker B, Mills DW. Corticosteroids and intraocular pressure. Arch Ophthalmol. 1963;70:500-507.
4. Goldman H. Cortisone glaucoma. Arch Ophthalmol. 1962;68:621-626.
5. Gerometta R, Podos SM, Candia OA, et al. Steroid-induced ocular hypertension in normal cattle. Arch Ophthalmol. 2004;122:1492-1497.
6. Tektas OY, Hammer CM, Danias J, et al. Morphologic changes in the outflow pathways of bovine eyes treated with corticosteroids. Invest Ophthalmol Vis Sci. 2010;51:4060-4066.
7. Rohen JW, Futa R, Lutjen-Drecoll E. The fine structure of the cribriform meshwork in normal and glaucomatous eyes as seen in tangential sections. Invest Ophthalmol Vis Sci. 1981;21:574-585.
8. Lutjen-Drecoll E, Futa R, Rohen JW. Ultrahistochemical studies on tangential sections of the trabecular meshwork in normal and glaucomatous eyes. Invest Ophthalmol Vis Sci. 1981;21:563-573.
9. Stamer WD, Seftor RE, Williams SK, Samaha HA, Snyder RW. Isolation and culture of human trabecular meshwork cells by extracellular matrix digestion. Curr Eye Res. 1995;14:611-617.
10. Hubbell E, Liu WM, Mei R. Robust estimators for expression analysis. Bioinformatics. 2002;18:1585-1592.
11. Wu Z, Irizarry RA. Stochastic models inspired by hybridization theory for short oligonucleotide arrays. J Comput Biol. 2005;12: 882-893.
12. Gentleman RC, Carey VJ, Bates DM, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004;5:Art R80.
13. Francois J. Cortisone et tension oculaire. Ann Ocul (Paris). 1954; 187:805-816.
14. Bollinger KE, Smith SD. Prevalence and management of elevated intraocular pressure after placement of an intravitreal sustainedrelease steroid implant. Curr Opin Ophthalmol. 2009;20:99-103.
15. Goldstein DA, Godfrey DG, Hall A, et al. Intraocular pressure in patients with uveitis treated with fluocinolone acetonide implants. Arch Ophthalmol. 2007;125:1478-1485.
16. Armaly MF. Effect of corticosteroids on intraocular pressure and fluid dynamics. II. The effect of dexamethasone in the glaucomatous eye. Arch Ophthalmol. 1963;70:492-499.
17. Wordinger RJ, Clark AF. Effects of glucocorticoids on the trabecular meshwork: towards a better understanding of glaucoma. Prog Retin Eye Res. 1999;18:629-667.
18. Jones R 3rd, Rhee DJ. Corticosteroid-induced ocular hypertension and glaucoma: a brief review and update of the literature. Curr Opin Ophthalmol. 2006;17:163-167.
19. Polansky JR, Weinreb RN, Baxter JD, Alvarado J. Human trabecular cells. I. Establishment in tissue culture and growth characteristics. Invest Ophthalmol Vis Sci. 1979;18:1043-1049.
20. Tripathi RC, Tripathi BJ. Human trabecular endothelium, corneal endothelium, keratocytes, and scleral fibroblasts in primary cell culture. A comparative study of growth characteristics, morphology, and phagocytic activity by light and scanning electron microscopy. Exp Eye Res. 1982;35:611-624.
21. Hernandez MR, Weinstein BI, Schwartz J, Ritch R, Gordon GG, Southren AL. Human trabecular meshwork cells in culture: morphology and extracellular matrix components. Invest Ophthalmol Vis Sci. 1987;28:1655-1660.
22. Wang DY, Fan BJ, Yam GY, Lam DS, Pang CP. The cytotoxic and stress responses of human trabecular meshwork cells treated with triamcinolone acetonide. Mol Vis. 2008;14:105-113.
23. Hoffman EA, Perkumas KM, Highstrom LM, Stamer WD. Regulation of myocilin-associated exosome release from human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 2009;50:1313-1318.
24. Johnson DH, Tschumper RC. Human trabecular meshwork organ culture. A new method. Invest Ophthalmol Vis Sci. 1987;28:945-953.
25. Urakawa Y, Miyazaki M, Ishihara A, Segawa K, Watanabe S, Shimizu Y. Human trabecular meshwork organ culture. Jpn J Ophthalmol. 1988;32:401-411.
26. Clark AF, Wilson K, de Kater AW, Allingham RR, McCartney MD. Dexamethasone-induced ocular hypertension in perfusion-cultured human eyes. Invest Ophthalmol Vis Sci. 1995;36:478-489.
27. el-Shabrawi Y, Eckhardt M, Berghold A, et al. Synthesis pattern of matrix metalloproteinases (MMPs) and inhibitors (TIMPs) in human explant organ cultures after treatment with latanoprost and dexamethasone. Eye. 2000;14:375-383.
28. Pang IH, McCartney MD, Steely HT, Clark AF. Human ocular perfusion organ culture: a versatile ex vivo model for glaucoma research. J Glaucoma. 2000;9:468-479.
29. Vittitow J, Borras T. Expression of optineurin, a glaucoma-linked gene, is influenced by elevated intraocular pressure. Biochem Biophys Res Commun. 2002;298:67-74.
30. Perruccio EM, Rowlette LL, Comes N, et al. Dexamethasone increases pigment epithelium-derived factor in perfused human eyes. Curr Eye Res. 2008;33:507-515.
31. Francois J, Benozzi G, Victoria-Troncoso V, Bohyn W. Ultrastructural and morphometric study of corticosteroid glaucoma in rabbits. Ophthalmic Res. 1984;16:168-178.
32. Zhan GL, Miranda OC, Bito LZ. Steroid glaucoma: corticosteroidinduced ocular hypertension in cats. Exp Eye Res. 1992;54:211-218.
33. Clark AF, Lane D, Wilson K, Miggans ST, McCartney MD. Inhibition of dexamethasone-induced cytoskeletal changes in cultured human trabecular meshwork cells by tetrahydrocortisol. Invest Ophthalmol Vis Sci. 1996;37:805-813.
34. Borras T. Gene expression in the trabecular meshwork and the influence of intraocular pressure. Prog Retin Eye Res. 2003;22: 435-463.
35. Borras T. What is functional genomics teaching us about intraocular pressure regulation and glaucoma? In: Civan MM, Benos DJ, Simon SA, eds. The Eye's Aqueous Humor. New York: Elsevier/ Academic Press; 2008:324-365.
36. Karali A, Russell P, Stefani FH, Tamm ER. Localization of myocilin/ trabecular meshwork-inducible glucocorticoid response protein in the human eye. Invest Ophthalmol Vis Sci. 2000;41:729-740.
37. Tripathi BJ, Millard CB, Tripathi RC. Corticosteroids induce a sialated glycoprotein (Cort-GP) in trabecular cells in vitro. Exp Eye Res. 1990;51:735-737.
38. Ticho U, Lahav M, Berkowitz S, Yoffe P. Ocular changes in rabbits with corticosteroid-induced ocular hypertension. Br J Ophthalmol. 1979;63:646-650.
39. Clark AF, Steely HT, Dickerson JE Jr, et al. Glucocorticoid induction of the glaucoma gene MYOC in human and monkey trabecular meshwork cells and tissues. Invest Ophthalmol Vis Sci. 2001;42: 1769-1780.
40. Diskin S, Kumar J, Cao Z, et al. Detection of differentially expressed glycogenes in trabecular meshwork of eyes with primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 2006;47:1491-1499.
41. Wang WH, McNatt LG, Pang IH, et al. Increased expression of serum amyloid A in glaucoma and its effect on intraocular pressure. Invest Ophthalmol Vis Sci. 2008;49:1916-1923.
42. Becker B. Intraocular pressure response to topical corticosteroids. Invest Ophthalmol Vis Sci. 1965;26:198-205.
43. Fingert JH, Clark AF, Craig JE, et al. Evaluation of the myocilin (MYOC) glaucoma gene in monkey and human steroid-induced ocular hypertension. Invest Ophthalmol Vis Sci. 2001;42:145-152.
44. Gerometta R, Podos SM, Danias J, Candia OA. Steroid-induced ocular hypertension in normal sheep. Invest Ophthalmol Vis Sci. 2009;50:669-673.
45. - concentrations of bovine, porcine and ovine aqueous humor are higher than in plasma. Exp Eye Res. 2005;80(3):307-312.
46. To CH, Do CW, Zamudio AC, Candia OA. Model of ionic transport for bovine ciliary epithelium: effects of acetazolamide and HCO. Am J Physiol Cell Physiol. 2001;280:C1521-C1530.
47. Steinhausen K, Stumpff F, Strauss O, Thieme H, Wiederholt M. Influence of muscarinic agonists and tyrosine kinase inhibitors on L-type Ca(2+) channels in human and bovine trabecular meshwork cells. Exp Eye Res. 2000;70:285-293.
48. Taniguchi F, Suzuki Y, Kurihara H, et al. Molecular cloning of the bovine MYOC and induction of its expression in trabecular meshwork cells. Invest Ophthalmol Vis Sci. 2000;41:2070-2075.
49. Thieme H, Hildebrandt J, Choritz L, Strauss O, Wiederholt M. Muscarinic receptors of the M2 subtype in human and bovine trabecular meshwork. Graefes Arch Clin Exp Ophthalmol. 2001; 239:310-315.
50. Tripathi RC. Ultrastructure of the exit pathway of the aqueous in lower mammals: a preliminary report on the "angular aqueous plexus. " Exp Eye Res. 1971;12:311-314.
51. Erickson-Lamy K, Schroeder AM, Bassett-Chu S, Epstein DL. Absence of time-dependent facility increase ("washout") in the perfused enucleated human eye. Invest Ophthalmol Vis Sci. 1990;31: 2384-2388.
52. Erickson-Lamy K, Rohen JW, Grant WM. Outflow facility studies in the perfused bovine aqueous outflow pathways. Curr Eye Res. 1988;7:799-807.
53. Scott PA, Overby DR, Freddo TF, Gong H. Comparative studies between species that do and do not exhibit the washout effect. Exp Eye Res. 2007;84:435-443.
54. Luo Z, Geschwind DH. Microarray applications in neuroscience. Neurobiol Dis. 2001;8:183-193.
55. Hofman P. DNA microarrays. Nephron Physiol. 2005;99:85-89.
56. Page GP, Zakharkin SO, Kim K, Mehta T, Chen L, Zhang K. Microarray analysis. Methods Mol Biol. 2007;404:409-430.
57. Tamm ER, Russell P, Epstein DL, Johnson DH, Piatigorsky J. Modulation of myocilin/TIGR expression in human trabecular meshwork. Invest Ophthalmol Vis Sci. 1999;40:2577-2582.
58. Etienne W, Meyer MH, Peppers J, Meyer RA Jr. Comparison of mRNA gene expression by RT-PCR and DNA microarray. BioTechniques. 2004;36:618-620, 622, 624-626.
59. Anderson MG, Smith RS, Hawes NL, et al. Mutations in genes encoding melanosomal proteins cause pigmentary glaucoma in DBA/2J mice. Nat Genet. 2001;30:81-85.
60. Liton PB, Li G, Luna C, Gonzalez P, Epstein DL. Cross-talk between TGF-beta1 and IL-6 in human trabecular meshwork cells. Mol Vis. 2009;15:326-334.
61. Agarwal R, Agarwal P. Future target molecules in antiglaucoma therapy: TGF-beta may have a role to play. Ophthalmic Res. 2010; 43:1-10.
62. Han H, Wecker T, Grehn F, Schlunck G. Elasticity-dependent modulation of TGF-β responses in human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 2011;52:2889-2896.
63. Hosseini M, Rose AY, Song K, et al. IL-1 and TNF induction of matrix metalloproteinase-3 by c-Jun N-terminal kinase in trabecular meshwork. Invest Ophthalmol Vis Sci. 2006;47:1469-1476.
64. Keller KE, Kelley MJ, Acott TS. Extracellular matrix gene alternative splicing by trabecular meshwork cells in response to mechanical stretching. Invest Ophthalmol Vis Sci. 2007;48:1164-1172.
65. Liang Y, Li C, Guzman VM, et al. Identification of a novel alternative splicing variant of RGS5 mRNA in human ocular tissues. FEBS J. 2005;272:791-799.
66. Narooie-Nejad M, Paylakhi SH, Shojaee S, et al. Loss of function mutations in the gene encoding latent transforming growth factor beta binding protein 2, LTBP2, cause primary congenital glaucoma. Hum Mol Genet. 2009;18:3969-3977.
67. Zhang X, Schroeder A, Callahan EM, et al. Constitutive signalling pathway activity in trabecular meshwork cells from glaucomatous eyes. Exp Eye Res. 2006;82:968-973.
68. Wang YL, Hayashi M, Yablonski ME, Toris CB. Effects of multiple dosing of epinephrine on aqueous humor dynamics in human eyes. J Ocul Pharmacol Ther. 2002;18:53-63.
69. Erickson-Lamy KA, Nathanson JA. Epinephrine increases facility of outflow and cyclic AMP content in the human eye in vitro. Invest Ophthalmol Vis Sci. 1992;33:2672-2678.
70. Alvarado JA, Murphy CG, Franse-Carman L, Chen J, Underwood JL. Effect of beta-adrenergic agonists on paracellular width and fluid flow across outflow pathway cells. Invest Ophthalmol Vis Sci. 1998;39:1813-1822.
71. Koch M, Laub F, Zhou P, et al. Collagen XXIV, a vertebrate fibrillar collagen with structural features of invertebrate collagens: selective expression in developing cornea and bone. J Biol Chem. 2003;278:43236-43244.
72. Gerometta R, Spiga MG, Borras T, Candia OA. Treatment of sheep steroid-induced ocular hypertension with a glucocorticoid-inducible MMP1 gene therapy virus. Invest Ophthalmol Vis Sci. 2010; 51:3042-3048.